Alpha Estate's wine maker’s choice. The best 17 barrels of each harvest are selected for the Alpha One, the absolute expression of the Amyndeon vineyard.
Style: Dry Red
Varietal Composition: Merlot 100%
Region: Amyndeon, North Greece
Ageing: 36 months in Jupille at 200% (18+18) new oak casks and 24 months in bottle. No treatment or filtration before bottling.
Analytical Alcohol: 13,75% vol., Total Acidity: 6,40 g/l, Residual Sugar: 1,70 g/l, pH: 3,31
Tasting Characteristics: Fine, rich, intense. Some black crystalline fruit, spices, and cassis. Quite complex, very long. Develops in mouth very well.
Harmony: Well paired with rich meat dishes, grilled or with rich sauces, cooked with vegetables, roots and wine. Marinated game, with chestnuts and plums. Full body mature creamy cheeses with intense and full flavour.
ALPHA ESTATE is situated in the “AMPELIA” region, in the heart of the Amyndeon district, an area of VQPRD wines in the northern part of Greece. Two factors contribute to the special character of ALPHA ESTATE grapes: meso-climate and soil. Moderate temperatures and heavy winter rains create ideal conditions for the grapes to ripen whilstoor soils with good drainage create a mild water deficit for the vines, resulting in small berries with intense red colour and concentrated flavours and aromas.
The privately owned vineyard of the estate is situated on a plateau at an altitude of 620-710 m with a northwest exposure, covering a total area of 65 hectares. The local climate is characterized by cold winters with sufficient rainfall and snow to provide the vines with the necessary water supplies to endure the relatively dry summer. Additionally, two neighbouring lakes contribute to the existence of a mild semi-continental climate perfect for the cultivation of both foreign and indigenous red and white grape varieties.
Alpha Estate’s vineyards produce the following grape varieties: Sauvignon Blanc, Gewürztraminer, Malagouzia, Pinot Noir, Negro Amaro, Montepulciano, Tannat, Barbera, Mavrodaphne, Merlot, Syrah and Xinomavro.